MoneyWorks4Me

Mangalam Drugs & Organics board to consider financial results

18 Jul 2012 Evaluate
Mangalam Drugs & Organics has informed that a meeting of the board of directors of the company will be held on July 23, 2012, to consider and approve the audited financial results for the year ended March 31, 2012 and to recommend dividend, if any.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..